Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA012107 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA012107, RRID:AB_1856610
- Product name
- Anti-SCD
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human SCD, Gene description: stearoyl-CoA desaturase (delta-9-desaturase), Alternative Gene Names: FADS5, SCDOS, Validated applications: WB, IHC, ICC, Uniprot ID: O00767, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.05 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Adipose-Derived Stem-Cell-Membrane-Coated PLGA-PEI Nanoparticles Promote Wound Healing via Efficient Delivery of miR-21
Blocking Ubiquitin-Specific Protease 7 Induces Ferroptosis in Gastric Cancer via Targeting Stearoyl-CoA Desaturase.
Interfering with lipid metabolism through targeting CES1 sensitizes hepatocellular carcinoma for chemotherapy
Generation and characterization of hair-bearing skin organoids from human pluripotent stem cells
Accelerated bottom-up drug design platform enables the discovery of novel stearoyl-CoA desaturase 1 inhibitors for cancer therapy
Aberrant Lipid Metabolism in Anaplastic Thyroid Carcinoma Reveals Stearoyl CoA Desaturase 1 as a Novel Therapeutic Target
Peng H, Du F, Wang J, Wu Y, Wei Q, Chen A, Duan Y, Shi S, Zhang J, Yu S
Pharmaceutics 2024;16(9):1113
Pharmaceutics 2024;16(9):1113
Blocking Ubiquitin-Specific Protease 7 Induces Ferroptosis in Gastric Cancer via Targeting Stearoyl-CoA Desaturase.
Guan X, Wang Y, Yu W, Wei Y, Lu Y, Dai E, Dong X, Zhao B, Hu C, Yuan L, Luan X, Miao K, Chen B, Cheng XD, Zhang W, Qin JJ
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024 May;11(18):e2307899
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024 May;11(18):e2307899
Interfering with lipid metabolism through targeting CES1 sensitizes hepatocellular carcinoma for chemotherapy
Li G, Li X, Mahmud I, Ysaguirre J, Fekry B, Wang S, Wei B, Eckel-Mahan K, Lorenzi P, Lehner R, Sun K
JCI Insight 2023;8(2)
JCI Insight 2023;8(2)
Generation and characterization of hair-bearing skin organoids from human pluripotent stem cells
Lee J, van der Valk W, Serdy S, Deakin C, Kim J, Le A, Koehler K
Nature Protocols 2022;17(5):1266-1305
Nature Protocols 2022;17(5):1266-1305
Accelerated bottom-up drug design platform enables the discovery of novel stearoyl-CoA desaturase 1 inhibitors for cancer therapy
von Roemeling C, Caulfield T, Marlow L, Bok I, Wen J, Miller J, Hughes R, Hazlehurst L, Pinkerton A, Radisky D, Tun H, Kim Y, Lane A, Copland J
Oncotarget 2017;9(1):3-20
Oncotarget 2017;9(1):3-20
Aberrant Lipid Metabolism in Anaplastic Thyroid Carcinoma Reveals Stearoyl CoA Desaturase 1 as a Novel Therapeutic Target
von Roemeling C, Marlow L, Pinkerton A, Crist A, Miller J, Tun H, Smallridge R, Copland J
The Journal of Clinical Endocrinology & Metabolism 2015;100(5):E697-E709
The Journal of Clinical Endocrinology & Metabolism 2015;100(5):E697-E709
No comments: Submit comment
No validations: Submit validation data